MTOR and non-small cell lung carcinoma: Despite that the change of phosphorylated mTOR was not significant possibly due to the amplification effect of a signaling cascade, the concurrent reducing of phosphorylated AKT and ERK indicated that T1551 blocked the activation of PI3K/AKT/mTOR and ERK pathways in NSCLC cell line.